An immunodominant neutralization epitope on the ‘thumb’ subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by phage display antibodies Free

Abstract

An antibody phage display library was produced from the splenocytes of mice immunized with an infectious vaccinia virus recombinant (WRRT) expressing the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1). The library was panned against HIV-1 RT. Two clones, 5F and 5G, which produced Fab fragments specific for RT, were isolated. Surprisingly, both 5F and 5G Fab fragments were capable of strongly inhibiting the RNA-dependent DNA polymerase activity of HIV-1 RT. A hybridoma cell line that produces the monoclonal antibody 7C4, which strongly inhibits RT activity, was established previously using splenocytes from mice immunized with WRRT by the same immunization protocol. The epitope recognized by 7C4 exists in the region of the template primer-binding sites (or the ‘helix clump’) of RT. By epitope mapping and competitive ELISA analysis, it was shown that the 5F and 5G Fab fragments were directed against the same, or a very closely related, epitope that is recognized by 7C4. The neutralizing activities of the 5F, 5G and 7C4 Fab fragments correlated with their affinities for HIV-1 RT. DNA sequencing indicated that the immunoglobulin genes of the heavy chains of 5G and 7C4, as well as those of the light chains of 5F and 5G, had the same origin. These results suggest that the neutralizing epitope, which is recognized by these antibodies, becomes immunodominant after repeated immunization of mice with WRRT. This unique epitope, HIV-1 RT-specific and immunodominant neutralizing epitope (HRSINE), is a logical target for new types of HIV-1 RT inhibitors and gene therapy.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-4-813
2001-04-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/4/0820813a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-4-813&mimeType=html&fmt=ahah

References

  1. Barbas C. F., Lerner R. A. 1991; Combinatorial immunoglobulin libraries on surface phage (phabs): rapid selection of antigen-specific Fabs. Comparative Methods in Enzymology 2:119–124
    [Google Scholar]
  2. Beard W. A., Stahl S. J., Kim H. R., Bebenek K., Kumar A., Strub M. P., Becerra S. P., Kunkel T. A., Wilson S. H. 1994; Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha helix in the thumb subdomain. Journal of Biological Chemistry 269:28091–28097
    [Google Scholar]
  3. Bebenek K., Beard W. A., Casas-Finet J. R., Kim H. R., Darden T. A., Wilson S. H., Kunkel T. A. 1995; Reduced frameshift fidelity and processivity of HIV-1 reverse transcriptase mutants containing alanine substitutions in helix H of the thumb subdomain. Journal of Biological Chemistry 270:19516–19523
    [Google Scholar]
  4. Burton D. R., Barbas C. F., Persson M. A., Koenig S., Chanock R. M., Lerner R. A. 1991; A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proceedings of the National Academy of Sciences, USA 88:10134–10137
    [Google Scholar]
  5. Cattaneo A., Biocca S. 1999; The selection of intracellular antibodies. Trends in Biotechnology 17:115–121
    [Google Scholar]
  6. Chiba J., Yamaguchi A., Suzuki Y., Nakano M., Zhu W., Ohba H., Saito A., Shinagawa H., Yamakawa Y., Kobayashi T., Kurata T. 1996; A novel neutralization epitope on the ‘thumb’ subdomain of human immunodeficiency virus type 1 reverse transcriptase revealed by a monoclonal antibody. Journal of General Virology 77:2921–2929
    [Google Scholar]
  7. Chiba J., Nakano M., Suzuki Y., Aoyama K., Ohba H., Kobayashi T., Yasuda A., Kojima A., Kurata T. 1997; Generation of neutralizing antibody to the reverse transcriptase of human immunodeficiency virus type 1 by immunizing of mice with an infectious vaccinia virus recombinant. Journal of Immunological Methods 207:53–60
    [Google Scholar]
  8. Frohman M. A., Dush M. K., Martin G. R. 1988; Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proceedings of the National Academy of Sciences, USA 85:8998–9002
    [Google Scholar]
  9. Gargano N., Biocca S., Bradbury A., Cattaneo A. 1996; Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. Journal of Virology 70:7706–7712
    [Google Scholar]
  10. Hermann T., Meier T., Gotte M., Heumann H. 1994; The ‘helix clump’ in HIV-1 reverse transcriptase: a new nucleic acid-binding motif common in nucleic acid polymerases. Nucleic Acids Research 22:4625–4633
    [Google Scholar]
  11. Hoffman A. D., Banapour B., Levy J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
    [Google Scholar]
  12. Hoshikawa N., Kojima A., Yasuda A., Takayashiki E., Masuko S., Chiba J., Sata T., Kurata T. 1991; Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. Journal of General Virology 72:2509–2517
    [Google Scholar]
  13. Kang A. S., Barbas C. F., Janda K. D., Benkovic S. J., Lerner R. A. 1991; Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proceedings of the National Academy of Sciences, USA 88:4363–4366
    [Google Scholar]
  14. Kohlstaedt L. A., Wang J., Friedman J. M., Rice P. A., Steitz T. A. 1992; Crystal structure at 3·5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783–1790
    [Google Scholar]
  15. Ledley F. D. 1995; Nonviral gene therapy: the promise of genes as pharmaceutical products. Human Gene Therapy 6:1129–1144
    [Google Scholar]
  16. Moss B. 1996; Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences, USA 93:11341–11348
    [Google Scholar]
  17. Powell M. D., Beard W. A., Bebenek K., Howard K. J., Le Grice S. F., Darden T. A., Kunkel T. A., Wilson S. H., Levin J. G. 1999; Residues in the alphaH and alphaI helices of the HIV-1 reverse transcriptase thumb subdomain required for the specificity of RNase H-catalyzed removal of the polypurine tract primer. Journal of Biological Chemistry 274:19885–19893
    [Google Scholar]
  18. Rader C., Barbas C. F.III. 1997; Phage display of combinatorial antibody libraries. Current Opinion in Biotechnology 8:503–508
    [Google Scholar]
  19. Rondon I. J., Marasco W. A. 1997; Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annual Review of Microbiology 51:257–283
    [Google Scholar]
  20. Sawyer J. R., Blattner F. R. 1991; Rapid detection of antigen binding by antibody fragments expressed in the periplasm of Escherichia coli. Protein Engineering 4:947–953
    [Google Scholar]
  21. Sugimoto M., Yamanouchi K. 1994; Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines. Vaccine 12:675–681
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-4-813
Loading
/content/journal/jgv/10.1099/0022-1317-82-4-813
Loading

Data & Media loading...

Most cited Most Cited RSS feed